verified SJR 0,515 · Q3 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q3 — Hematology lock_open Open Access

Hematology

Hematology is a journal indexed in SJR in Hematology with an H index of 52. It has a price of 2840 €. It has an SJR impact factor of 0,515 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,515.

ISSN: 1024-5332

Publisher: Taylor and Francis Ltd.

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,515 Q3

H-index 52

Acceptance rate pie_chart

32%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.840 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,515

H-index

Docs (year)

158

Docs 3y

487

Total refs

5376

Cites 3y

850

Citable 3y

477

Cites/Doc 2y

1.63

Ref/Doc

34.03

Immediate OA

2840 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome

The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells

Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis

Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come

Recombinant Factor VIIa used to Control Massive Haemorrhage During Renal Transplantation Surgery; Vascular Graft Remained Patent

Predictive parameters for imatinib failure in patients with chronic myeloid leukemia

Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome

Molecular analysis of patients with severe congenital factor X deficiency: First report from north and northwest of Iran

Modeling for tertiary structure of globin chain in Hemoglobin Suan-Dok disorder

Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma

Lymphoproliferative Disease

Iron deficiency anaemia and evaluation of the utility of iron deficiency indicators among healthy Nigerian children

SHOW MORE ARTICLES

Hereditary hemochromatosis

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases

Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern Gabon

GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome

Fish consumption and risk of non-Hodgkin lymphoma: A meta-analysis of observational studies

Evaluation of growth parameters in patients with thalassemia major

Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging

Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1a after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause

Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis

Clonal expanded TCR Vbeta T cells in patients with APL

Clinical and Laboratory Study of an Episode of Cefotetan-Induced Severe Hemolytic Anemia

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

FAQs

Hematology has an SJR of 0,515 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2840 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Hematology is 32%.

Hematology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Hematology?

What is the APC / publication cost?

What is the acceptance rate?